Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease - Frick, M H; Elo, O; Haapa, K (N Engl J Med, 1987)
et al.